2-Naphthalenecarboxaldehyde,5,6,7,8-tetrahydro-3,5,5,6,7,8,8-heptamethyl- (140478-25-7)

Identification
Name:	2-Naphthalenecarboxaldehyde,5,6,7,8-tetrahydro-3,5,5,6,7,8,8-heptamethyl-
CAS:	140478-25-7
Molecular Formula:	C₁₈H₂₆O
Molecular Structure:
Properties
Safety Data

Other Product

[2,2'-Binaphthalene]-6-carboxaldehyde,3'-(dimethylamino)-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-
[2,2'-Binaphthalene]-6-carboxylicacid, 5',6',7',8'-tetrahydro-3',5',5',8',8'-pentamethyl-
Dispiro[cyclopropane-1,2'(10'H)-phenanthrene-10',2''-phenanthro[3,4-d][1,3]dioxole]-1',4',6'',9'(3'H,8''H)-tetrone,3',6'-bis(acetyloxy)-4'b,5',6',7',8',8'a,9'',10'',11'',11''a-decahydro-5'',7''-dihydroxy-2,4'b,8',8',8'',8'',11''a-heptamethyl-4''-(1-methylethyl)-,(1'S,2S,2''R,3'R,4'bS,6'S,8'aS)- (9CI)
Dispiro[cyclopropane-1,2'(10'H)-phenanthrene-10',2''-phenanthro[3,4-d][1,3]dioxole]-1',4',6'',9'(3'H,8''H)-tetrone,3',6'-bis(acetyloxy)-4'b,5',6',7',8',8'a,9'',10'',11'',11''a-decahydro-5'',7''-dihydroxy-2,4'b,8',8',8'',8'',11''a-heptamethyl-4''-(1-methylethyl)-,(1'S,2S,2''S,3'R,4'bS,6'S,8'aS)- (9CI)
[2,2'-Binaphthalene]-6-carboxylicacid, 5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-
[2,2'-Binaphthalene]-6-carboxylicacid, 5'-azido-5',6',7',8'-tetrahydro-8',8'-dimethyl-
N-[4-(3 3 4 4 5 5 6 6 7 7 8 8 8-TRIDECAF
(R)-SPIRO[1,3-DIOXOLANE-2,1'(2'H)-NAPHTHALEN]-6'(5'H)-ONE, 3',7',8',8'A-TETRAHYDRO-8'A-METHYL- (9CI)
Spiro[3H-benz[e]indene-3,9'-[9H-3,9a]methano- [1]benzoxepin]-2',8(2H,3'H)-dione,4,5',6',7'- tetrakis(acetyloxy)-1,3a,4,4',5,5',5a,5'a,6',7',8',9,- 9a,9b-tetradecahydro-8'-hydroxy-7-methoxy- 2,3',5a,5'a,6,8',9b-heptamethyl-,(2S,3S,3'R,- 3aS,4R,5'S,5aS,5'aR,6'R,7'R,8'R,9aS,9bS,9'aR)-
[2,2'-Binaphthalene]-6-sulfonic acid, 5',6',7',8'-tetrahydro-8',8'-dimethyl-,sodium salt
[2,2'-Binaphthalene]-6-carboxylicacid, 5',6',7',8'-tetrahydro-8',8'-dimethyl-
2,2':3',2'':3'',2''':3''',2'''':3'''',2'''''-Sexiquinoxaline,5,5',5'',5''',5'''',5''''',6,6',6'',6''',6'''',6''''',7,7',7'',7''',7'''',7''''',8,8',8'',8''',8'''',8'''''-tetracosamethyl-3-(1-methylethyl)-
2,2':3',2'':3'',2''':3''',2'''':3'''',2'''''-Sexiquinoxaline,5,5',5'',5''',5'''',5''''',6,6',6'',6''',6'''',6''''',7,7',7'',7''',7'''',7''''',8,8',8'',8''',8'''',8'''''-tetracosamethyl-3-(1-methylpropyl)-
[1,2'-Bianthracene]-9,9',10,10'-tetrone,5',6',7',8'-tetrahydro-1',2,5',6',7',8,8'-heptahydroxy-3',6-dimethoxy-3,6'-dimethyl-,(5'R,6'S,7'R,8'S)- (9CI)
(3R,5'R,6'R)-7,8-Didehydro-5',6',7',8'-tetrahydro-3,6'-dihydroxy-β,β-carotene-3',8'-dione
5'',6'',7'',8''-TETRAHYDRO-3''H-SPIRO[CYCLOHEXANE-1,4''-QUINAZOLINE]-2''-THIOL
5',6',7',8'-TETRAHYDRO-3'H-SPIRO[CYCLOHEXANE-1,4'-QUINAZOLINE]-2'-THIOL
Spiro[cyclohexane-1,2'-[2H]imidazo[4,5-g]quinoxaline],5',6',7',8'-tetrahydro-5',8'-dimethyl-
2-Naphthalenecarboxaldehyde,5,6,7,8-tetrahydro-5-hydroxy-3-methoxy-5-methyl-8-(1-methylethyl)-,(5R,8S)-rel-
Spiro[3H-indole-3,1'(5'H)-indolizin]-2(1H)-one,6'-ethyl-2',3',6',7',8',8'a-hexahydro-7'-(2-hydroxyethyl)-, (1'S,6'R,7'R,8'aS)-